Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal Marco Proietti,1–3 Giuseppe Boriani4 1Department of Neuroscience, IRCCS – Istituto di Ricerche Farmacologiche
, Sapienza-University of Rome, Rome, ItalyMarco ProiettiAalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, DenmarkGregory Y. H. Lip AuthorsSearch for Marco Proietti
Background In patients with atrial fibrillation (AF), quality of oral anticoagulation control as well as impaired renal function are associated with adverse outcomes. Our objective was to analyze if there was a synergistic impact of these factors in determining adverse outcomes in AF patients undergoing percutaneous coronary intervention and stent (PCI-S). Methods Post-hoc...
Roberto Cangemi Pasquale Pignatelli Roberto Carnevale Carmen Nigro Marco Proietti Francesco Angelico Davide Lauro Stefania Basili Francesco Violi Aspirin modestly influences cardiovascular events in